blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1530483

EP1530483 - T CELL RECEPTOR CDR3 SEQUENCES AND METHODS FOR DETECTION [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  05.11.2010
Database last updated on 15.07.2024
Most recent event   Tooltip19.10.2012Lapse of the patent in a contracting state
New state(s): TR		published on 21.11.2012  [2012/47]
Applicant(s)For all designated states
BAYLOR COLLEGE OF MEDICINE
One Baylor Plaza
Houston, TX 77030 / US
For all designated states
Opexa Pharmaceuticals, Inc.
835 Green Parkway, Suite 150
Houston, TX 77067 / US
[2010/01]
Former [2005/20]For all designated states
BAYLOR COLLEGE OF MEDICINE
One Baylor Plaza
Houston, TX 77030 / US
For all designated states
Opexa Pharmaceuticals, Inc.
835 Green Parkway, Suite 150
Houston, TX 77067 / US
Inventor(s)01 / ZHANG, Jingwu, Z.
2219 Parkview Lane
Missouri City, TX 77459 / US
 [2005/20]
Representative(s)Walton, Seán Malcolm
Mewburn Ellis LLP
Aurora Building
Counterslip
Bristol BS1 6BX / GB
[N/P]
Former [2005/20]Walton, Seán Malcolm
Mewburn Ellis LLP York House, 23 Kingsway
London WC2B 6HP / GB
Application number, filing date03736888.305.06.2003
[2005/20]
WO2003US17873
Priority number, dateUS20020386287P05.06.2002         Original published format: US 386287 P
[2005/20]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO03104407
Date:18.12.2003
Language:EN
[2003/51]
Type: A2 Application without search report 
No.:EP1530483
Date:18.05.2005
Language:EN
The application published by WIPO in one of the EPO official languages on 18.12.2003 takes the place of the publication of the European patent application.
[2005/20]
Type: B1 Patent specification 
No.:EP1530483
Date:30.12.2009
Language:EN
[2009/53]
Search report(s)International search report - published on:US24.03.2005
(Supplementary) European search report - dispatched on:EP31.03.2006
ClassificationIPC:C12Q1/68, A61K39/00, C07H21/04
[2006/08]
CPC:
C07K14/7051 (EP); A61P1/04 (EP); A61P19/02 (EP);
A61P21/00 (EP); A61P21/04 (EP); A61P25/00 (EP);
A61P27/02 (EP); A61P29/00 (EP); A61P3/10 (EP);
A61P37/00 (EP); A61P37/02 (EP); A61P5/16 (EP);
C12Q1/6883 (EP); A61K38/00 (EP) (-)
Former IPC [2005/20]A61K39/00, C12Q1/68, C07H21/04
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2005/20]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
TitleGerman:SEQUENZEN DES T-ZELLREZEPTORS CDR3 UND NACHWEISVERFAHREN[2005/20]
English:T CELL RECEPTOR CDR3 SEQUENCES AND METHODS FOR DETECTION[2005/20]
French:SEQUENCES CDR3 DES RECEPTEURS DES LYMPHOCYTES T ET PROCEDES DE DETECTION ASSOCIES[2005/20]
Entry into regional phase24.12.2004National basic fee paid 
24.12.2004Search fee paid 
24.12.2004Designation fee(s) paid 
24.12.2004Examination fee paid 
Examination procedure24.12.2004Examination requested  [2005/20]
05.01.2005Request for preliminary examination filed
International Preliminary Examining Authority: US
27.06.2006Amendment by applicant (claims and/or description)
03.08.2006Despatch of a communication from the examining division (Time limit: M04)
09.10.2006Reply to a communication from the examining division
25.01.2007Despatch of a communication from the examining division (Time limit: M06)
02.07.2007Reply to a communication from the examining division
23.07.2007Despatch of a communication from the examining division (Time limit: M02)
02.10.2007Reply to a communication from the examining division
08.07.2009Communication of intention to grant the patent
13.11.2009Fee for grant paid
13.11.2009Fee for publishing/printing paid
Opposition(s)01.10.2010No opposition filed within time limit [2010/49]
Fees paidRenewal fee
14.06.2005Renewal fee patent year 03
14.06.2006Renewal fee patent year 04
14.06.2007Renewal fee patent year 05
23.06.2008Renewal fee patent year 06
22.06.2009Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT30.12.2009
BE30.12.2009
CY30.12.2009
CZ30.12.2009
DK30.12.2009
EE30.12.2009
FI30.12.2009
IT30.12.2009
NL30.12.2009
RO30.12.2009
SE30.12.2009
SI30.12.2009
SK30.12.2009
TR30.12.2009
BG30.03.2010
GR31.03.2010
ES10.04.2010
PT30.04.2010
IE05.06.2010
LU05.06.2010
CH30.06.2010
LI30.06.2010
MC30.06.2010
HU01.07.2010
[2012/47]
Former [2012/43]AT30.12.2009
BE30.12.2009
CY30.12.2009
CZ30.12.2009
DK30.12.2009
EE30.12.2009
FI30.12.2009
IT30.12.2009
NL30.12.2009
RO30.12.2009
SE30.12.2009
SI30.12.2009
SK30.12.2009
BG30.03.2010
GR31.03.2010
ES10.04.2010
PT30.04.2010
IE05.06.2010
LU05.06.2010
CH30.06.2010
LI30.06.2010
MC30.06.2010
HU01.07.2010
Former [2012/42]AT30.12.2009
BE30.12.2009
CY30.12.2009
CZ30.12.2009
DK30.12.2009
EE30.12.2009
FI30.12.2009
IT30.12.2009
NL30.12.2009
RO30.12.2009
SE30.12.2009
SI30.12.2009
SK30.12.2009
BG30.03.2010
GR31.03.2010
ES10.04.2010
PT30.04.2010
IE05.06.2010
CH30.06.2010
LI30.06.2010
MC30.06.2010
HU01.07.2010
Former [2011/20]AT30.12.2009
BE30.12.2009
CY30.12.2009
CZ30.12.2009
DK30.12.2009
EE30.12.2009
FI30.12.2009
IT30.12.2009
NL30.12.2009
RO30.12.2009
SE30.12.2009
SI30.12.2009
SK30.12.2009
BG30.03.2010
GR31.03.2010
ES10.04.2010
PT30.04.2010
IE05.06.2010
CH30.06.2010
LI30.06.2010
MC30.06.2010
Former [2011/19]AT30.12.2009
BE30.12.2009
CY30.12.2009
CZ30.12.2009
DK30.12.2009
EE30.12.2009
FI30.12.2009
IT30.12.2009
NL30.12.2009
RO30.12.2009
SE30.12.2009
SI30.12.2009
SK30.12.2009
BG30.03.2010
GR31.03.2010
ES10.04.2010
PT30.04.2010
IE05.06.2010
MC30.06.2010
Former [2011/14]AT30.12.2009
BE30.12.2009
CY30.12.2009
CZ30.12.2009
DK30.12.2009
EE30.12.2009
FI30.12.2009
IT30.12.2009
NL30.12.2009
RO30.12.2009
SE30.12.2009
SI30.12.2009
SK30.12.2009
BG30.03.2010
GR31.03.2010
ES10.04.2010
PT30.04.2010
MC30.06.2010
Former [2011/07]AT30.12.2009
BE30.12.2009
CY30.12.2009
CZ30.12.2009
DK30.12.2009
EE30.12.2009
FI30.12.2009
NL30.12.2009
RO30.12.2009
SE30.12.2009
SI30.12.2009
SK30.12.2009
BG30.03.2010
GR31.03.2010
ES10.04.2010
PT30.04.2010
MC30.06.2010
Former [2010/48]AT30.12.2009
BE30.12.2009
CY30.12.2009
CZ30.12.2009
EE30.12.2009
FI30.12.2009
NL30.12.2009
RO30.12.2009
SE30.12.2009
SI30.12.2009
SK30.12.2009
BG30.03.2010
GR31.03.2010
ES10.04.2010
PT30.04.2010
Former [2010/39]AT30.12.2009
BE30.12.2009
CZ30.12.2009
EE30.12.2009
FI30.12.2009
NL30.12.2009
RO30.12.2009
SE30.12.2009
SI30.12.2009
SK30.12.2009
BG30.03.2010
ES10.04.2010
PT30.04.2010
Former [2010/37]AT30.12.2009
BE30.12.2009
CZ30.12.2009
EE30.12.2009
FI30.12.2009
NL30.12.2009
RO30.12.2009
SE30.12.2009
SI30.12.2009
BG30.03.2010
ES10.04.2010
PT30.04.2010
Former [2010/36]AT30.12.2009
CZ30.12.2009
EE30.12.2009
FI30.12.2009
NL30.12.2009
RO30.12.2009
SE30.12.2009
SI30.12.2009
BG30.03.2010
ES10.04.2010
PT30.04.2010
Former [2010/35]AT30.12.2009
EE30.12.2009
FI30.12.2009
NL30.12.2009
RO30.12.2009
SE30.12.2009
SI30.12.2009
BG30.03.2010
ES10.04.2010
PT30.04.2010
Former [2010/32]AT30.12.2009
FI30.12.2009
SE30.12.2009
SI30.12.2009
ES10.04.2010
Former [2010/30]AT30.12.2009
FI30.12.2009
SE30.12.2009
SI30.12.2009
Former [2010/23]FI30.12.2009
SE30.12.2009
SI30.12.2009
Former [2010/22]FI30.12.2009
SE30.12.2009
Documents cited:Search[X]WO9115225  (BRIGHAM & WOMENS HOSPITAL [US], et al) [X] 1-17 * abstract * * page 33, line 35 - page 34, line 7; table 7 * * page 36 - page 39; claims 1-17 *;
 [X]WO0050641  (BAYLOR COLLEGE MEDICINE [US]) [X] 1-17 * abstract * * page 20 - page 22 *;
 [X]  - KOZOVSKA M ET AL, "T CELL RECOGNITION MOTIFS OF AN IMMUNODOMINANT PEPTIDE OF MYELIN BASIC PROTEIN IN PATIENTS WITH MULTIPLE SCLEROSIS: STRUCTURAL REQUIREMENTS AND CLINICAL IMPLICATIONS", EUROPEAN JOURNAL OF IMMUNOLOGY, WEINHEIM, DE, (1998), vol. 28, ISSN 0014-2980, pages 1894 - 1901, XP002928182 [X] 1-17 * abstract *

DOI:   http://dx.doi.org/10.1002/(SICI)1521-4141(199806)28:06<1894::AID-IMMU1894>3.0.CO;2-W
International search[Y]  - MARTIN R. ET AL., "A myelin basic protein peptide is recognized by cytotoxic T cells in the context of four HLA-DR types associated with multiple sclerosis", J. EXP. MED., (199101), vol. 173, pages 19 - 24, XP000578296

DOI:   http://dx.doi.org/10.1084/jem.173.1.19
 [Y]  - HONG J. ET AL., "A common TCR V-D-J sequence in Vbeta13.1 T cells recognizing an immunodominant peptide of myeline basic protein in multiple sclerosis", J. IMMUNOL., (1999), vol. 163, pages 3530 - 3538, XP002928174
 [Y]  - HONG J. ET AL., "Reactivity and regulatory properties of human anti-idiotypic antibodies induced by T cell regulation", J. IMMUNOL., (2000), vol. 165, pages 6858 - 6864, XP002984334
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.